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Right ventricular (RV) structure and function serve as impor-
tant indicators of a wide spectrum of heart diseases such as
congenital heart disease, pulmonary hypertension, hypertro-
phic cardiomyopathy and arrhythmogenic right ventricular
cardiomyopathy/disease (ARVC/D) [1–3]. Over the past years
cardiac magnetic resonance imaging (CMR) has proven itself
as the preferred imaging modality of choice to evaluate RV
anatomy, structure, texture, motion and function [4–9]. In the
study by Quick et al. [10], published in the current issue of the
Netherlands Heart Journal, a quantitative analysis of normal
variations in RV wall motion was evaluated in healthy sub-
jects using CMR. The study population consisted of 65 con-
secutive patients referred for the evaluation of cardiac function
by 3 Tesla-CMR. All subjects were shown to be free of heart
disease based on the currently available guidelines for CMR.
Balanced steady-state free-precession images were obtained
and regional RV wall motion was evaluated and classified
based on a standardised segmental model for the right ventri-
cle. In 59 out of 65 subjects (>90 %) wall motion abnormal-
ities of the right ventricle were observed. Wall motion abnor-
malities were predominantly seen in the apico-lateral seg-
ments (72 %) when compared with the medio-lateral (24 %)
and infero-lateral segments (4 %). Dyskinesia was the most
frequent wall motion disorder (62 %), followed by
hypokinesia (21 %) and bulging (17 %). The authors conclud-
ed that RV wall motion abnormalities are common in subjects
supposed to be normal, indicating that one should be aware of
the notion that non-pathological wall motion disorders can
easily be mistaken for a pathological regional wall motion
abnormality, particularly in patients with ARVC where –
according to the authors- to date, clear wall motion criteria
are lacking.
The study is certainly very interesting in the sense that the
right ventricle in normal subjects does not always appear
normal when visualised by CMR. Especially, regional wall
motion abnormalities are predominantly seen in the apico-
lateral segments. However, the study warrants the following
three comments. First, also acknowledged by the authors, the
study was based on a small patient population. As a result, the
description of normal variations in RV morphology as ob-
served by CMR are not necessarily absolute and should only
be regarded as hypothesis-generating for studying larger pa-
tient samples. Second, according to the authors, there is sup-
posedly no in-depth knowledge on RV motion in healthy
subjects. This is an obvious understatement as already in
2004 Pennell’s group (London, UK) showed that CMR dem-
onstrated good inter-study reproducibility for RV function
parameters in 20 healthy subjects, in 20 patients with heart
failure, and in 20 patients with hypertrophy, suggesting that
CMR is reliable for serial RV assessment [11]. In 2008,
Youssef et al. [12] showed in 21 healthy subjects that the
strain-encoding CMR technique allowed for rapid quantifica-
tion of RV regional function with low intra- and inter-observer
variability, permitting accurate quantification of regional strain
in patients with RV dysfunction. Rather recently, Von
Knobelsdorff-Brenkenhoff et al. [13], in nine healthy subjects,
showed that fast-gradient echo cine imaging of the RV at 7
Tesla-CMRwas feasible and provided good image quality; RV
dimensions and function were comparable with steady-state
free-precession at 1.5 Tesla-CMR as gold standard. Doesch
et al. [14] showed in 20 healthy subjects that CMR-derived
measurement of the tricuspid annular plane systolic excursion
with a reference point outside the ventricle (TAPSEout) might
be used for screening RV motion; however, the detection of
subtle changes in RV function requires the 3D volumetric
CMR approach. Third, and most importantly, Quick et al.
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[10] rather firmly state, that -particularly in ARVC patients- ‘to
date clear wall motion criteria are lacking’. However, the re-
vised ARVC/D diagnostic Task Force Criteria, already dating
from 2010, incorporate clear CMR-defined cut-off values for
RVejection fraction and RVend-diastolic volume for ARVC [3,
15]. More specifically, the 2010 ARVC/D Task Force Criteria
include the following parameters for CMR: 1) regional RV
akinesia or dyskinesia or dyssynchronous RV contraction, 2)
ratio of RV end-diastolic volume to BSA ≥110 mL/m2 (male)
or ≥100 mL/m2 (female), or RVejection fraction ≤40 %. Used
in this way, CMR-derived RV ejection fraction can help in
distinguishing ARVC/D from both normal subjects and/or from
the physiological cardiac adaptation in athletes [3, 15].
To summarise, despite the above-mentioned critical com-
ments, the study by Quick et al. [10] is a valuable contribution
to our understanding of CMR-derived RV function in normal
subjects. The study clearly shows that RV wall motion abnor-
malities may occur both in normal subjects and in diseased
patients, in particular those with ARVC. Fortunately, CMR-
derived parameters, as defined by the 2010 ARVC/D Task
Force Criteria, may provide a major discriminatory role.
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